US Stock MarketDetailed Quotes

MRSN Mersana Therapeutics

Watchlist
  • 2.605
  • -0.015-0.57%
Trading May 14 15:56 ET
318.75MMarket Cap-2325P/E (TTM)

Mersana Therapeutics Key Stats

Mersana Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 9, 2024

Revenue(YoY)

9.24M

+18.50%
EPS(YoY)

-0.16

+69.23%

Strong Buy

May 14, 2024

Mersana Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 8.816M--
--2024/Q2-- / 8.542M--
May 9, 20242024/Q19.245M / 8.289M--
Feb 28, 20242023/Q410.701M / 14.772M--
Nov 7, 20232023/Q37.698M / 9.344M--
--2023/Q210.654M / 12.955M--
May 9, 20232023/Q17.802M / 18.286M--
Feb 28, 20232022/Q414.688M / 13.671M--
Nov 7, 20222022/Q35.573M / 56.783M--
Aug 8, 20222022/Q24.284M / 2.202M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 8.816M--
--2024/Q2-- / 8.542M--
May 9, 20242024/Q19.245M / 8.289M--
Feb 28, 20242023/Q410.701M / 14.772M--
Nov 7, 20232023/Q37.698M / 9.344M--
--2023/Q210.654M / 12.955M--
May 9, 20232023/Q17.802M / 18.286M--
Feb 28, 20232022/Q414.688M / 13.671M--
Nov 7, 20222022/Q35.573M / 56.783M--
Aug 8, 20222022/Q24.284M / 2.202M--

Unlock Free Earnings Estimates

Mersana Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 14, 2024

Strong Buy

  • Buy

    75.00%
  • Hold

    25.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg